Cytomx Therapeutics Inc. (CTMX)

Market is closed

Hedge Fund Holdings

Filing Period:

Last updated on February 14, 2024, 4:59 pm based on SEC 13F filings Last update: February 14, 2024, 4:59 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Biotechnology Value Fund / BVF Inc Mark Lampert	6,595,801	$10,223,492		0.25%
2.	Tang Capital Management Kevin C. Tang	6,550,000	$10,152,500	+2%	0.93%
3.	Laurion Capital Management Benjamin A. Smith	1,093,921	$1,695,578	-8%	0.01%
4.	Bronte Capital John Hempton	919,911	$1,425,862	-1%	0.13%
5.	Millennium Management Israel Englander	794,047	$1,230,773	+14%	0%